Editorial
Published on 27 Sep 2023
Editorial: Different cell death modes in cancer treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1291585
- 1,098 views
Type at least 3 characters
2,068 articles
Review
Published on 27 Sep 2023
Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1269233
- 2,669 views
- 7 citations
Original Research
Published on 26 Sep 2023
METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1257410
- 2,639 views
- 7 citations
Review
Published on 25 Sep 2023
A literature review: mechanisms of antitumor pharmacological action of leonurine alkaloid
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1272546
- 4,602 views
- 14 citations
Review
Published on 25 Sep 2023
The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1228985
- 3,740 views
- 4 citations
Original Research
Published on 25 Sep 2023
Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1128312
- 3,152 views
- 10 citations
Review
Published on 25 Sep 2023
Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1226629
- 5,127 views
- 5 citations
Original Research
Published on 21 Sep 2023
The construction of a prognostic model of cervical cancer based on four immune-related LncRNAs and an exploration of the correlations between the model and oxidative stress
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1234181
- 2,257 views
- 2 citations
Original Research
Published on 21 Sep 2023
Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1271268
- 4,285 views
- 7 citations
Review
Published on 21 Sep 2023
Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1271321
- 3,855 views
- 6 citations
Review
Published on 21 Sep 2023
Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1225951
- 4,902 views
- 3 citations
Original Research
Published on 21 Sep 2023
Evaluation of anti-cancer effects of carnosine and melittin-loaded niosomes in MCF-7 and MDA-MB-231 breast cancer cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1258387
- 4,147 views
- 17 citations
Original Research
Published on 20 Sep 2023
Synthesis and biological evaluation of novel 1,2,3-triazole hybrids of cabotegravir: identification of potent antitumor activity against lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1265245
- 2,371 views
- 5 citations
Original Research
Published on 19 Sep 2023
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1223632
- 2,787 views
- 6 citations
Review
Published on 19 Sep 2023
Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1269863
- 11,325 views
- 13 citations
Review
Published on 19 Sep 2023
Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1230824
- 5,561 views
- 6 citations